Studies to Enhance FDA Communications Addressing Medical Countermeasures Prescription Drug Products

IMPROVE Study Phase 2

OMB: 0910-0695

IC ID: 226226

Documents and Forms
Document Name
Document Type
Other-Invitation
Other-Online Informed Consent Form
Other-Privacy Statement for Knowledg
IC Document
Information Collection (IC) Details

View Information Collection (IC)

Studies to Enhance FDA Communications Addressing Medical Countermeasures Prescription Drug Products CDER
 
New
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Invitation 0695 Appendix 1 - Email Invitation.doc Yes Yes Fillable Fileable
Other-Online Informed Consent Form 0695 Appendix 2 - Consent Form.doc Yes Yes Fillable Fileable
Other-Privacy Statement for KnowledgePanel Members 0695 Appendix 3 - Privacy Statement for Members.doc Yes Yes Fillable Fileable

Health Consumer Health and Safety

 

2,469 0
   
Individuals or Households
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 2,469 0 2,469 0 0 0
Annual IC Time Burden (Hours) 823 0 823 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
Communications Addressing Medical Countermeasures PDP OMB Approval Request Memo 0695 MEDICAL COUNTERMEASURES Study Re Medical Products OMB Approval Request Memo.doc 03/29/2017
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.
© 2024 OMB.report | Privacy Policy